The Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) has recommended approval of daridorexant (Quviviq, Idorsia Pharmaceuticals) for the treatment of insomnia. Daridorexant is a dual orexin receptor antagonist that has been shown to increase sleep induction, improve sleep maintenance, and improve daytime functioning. The drug is indicated for the […]